Revance Therapeutics

Patent cliffs & loss of exclusivity

A company that develops and commercializes products for the treatment of dermatological diseases

Company

AngelList URLhttps://angel.co/revance-therapeutics
CAGE Code6PA56
Legal NameRevance Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.revance.com/company/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/revance-therapeutics
Facebook URLhttps://www.facebook.com/realrevancetherapeutics/
Full Address1222 Demonbreun St 20th Floor Nashville, TN 37203

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. DaxxifydaxibotulinumtoxinA-lanmBiologicSep 2034
  2. DaxxifydaxibotulinumtoxinA-lanmBiologicSep 2034

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Revance Therapeutics — patent cliffs & loss of exclusivity | CliffBio